Effect of ornithine in parenteral nutrition regimens on difluoromethylornithine-induced platelet suppression and changes in tumor polyamine content

Cancer Investigation

Volumn 16, Issue 3, 1998, Pages 160-165

  Grossie Jr , V Bruce ^a,b   Nishioka, Kenji ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EFLORNITHINE; ORNITHINE; POLYAMINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; COLON TUMOR; NONHUMAN; PARENTERAL NUTRITION; PRIORITY JOURNAL; RAT; THROMBOCYTE COUNT; THROMBOCYTOPENIA;

EID: 2642686617     PISSN: 07357907     EISSN: None     Source Type: Journal    
DOI: 10.3109/07357909809050030     Document Type: Article

References (13)

1. Pegg AE: Polyamine metabolism and its importance in neoplastic growth and as a target for chemotherapy. Cancer Res 48:759-774, 1988.
2. Tabor CW, Tabor H: Polyamines. Annu Rev Biochem 53: 749-790, 1984.
3. Ajani JA, Ota DM, Grossie VB Jr, Levin B, Nishioka K: Alterations in polyamine metabolism during continuous intravenous infusion of alpha-difluoromethylornithine: Correlation of thrombocytopenia with alpha-difluoromethylornithine plasma levels. Cancer Res 49:5761-5765, 1989.
4. Grossie VB Jr, Ota DM, Ajani JA, Chang T-H, Patenia D, Nishioka K: Reduction of difluoromethylornithine induced thrombocytopenia with ornithine while maintaining antitumor activity. Cancer Res 49:4159-4162, 1989.
5. Grossie VB Jr, Ota DM, Ajani JA, Nishioka K: Amelioration of thrombocytopenia with concomitant ornithine in sarcoma-bearing rats receiving high dose DFMO. Invest New Drugs 9:321-326, 1991.
6. O'Brien TG, Madara T, Pyle JA, Holmes M: Ornithine decarboxylase from mouse epidermis and epidermal papillomas: Differences in enzymatic properties and structure. Proc Natl Acad Sci USA 83:9448-9456, 1986.
7. O'Brien TG, Hietala O, O'Donnell K, Holmes M: Activation of mouse epidermal tumor ornithine decarboxylase by GTP: Evidence for different catalytic forms of the enzyme. Proc Natl Acad Sci USA 84:8927-8931, 1987.
8. Grossie VB Jr, Nishioka K: Nutritional modifications, polyamines, and cancer. In: Critical Roles of Polyamines in Cancer: Basic Mechanisms and Clinical Approaches, edited by K. Nishioka, Georgetown, TX, RG Landes Co., 1996.
9. Nishioka K, Grossie VB Jr, Ajani JA, Patenia D, Chang T-H, Ota D: Polyamine directed preferential nutritional repletion of normal tissues in tumor-bearing hosts. Int J Cancer 42:744-747, 1988.
10. Grossie VB Jr, Nishioka K, Ajani JA, Ota DM: Substituting ornithine for arginine in total parenteral nutrition eliminates enhanced tumor growth. J Surg Oncol 50:161-167, 1992.
11. Grove J, Gozard JR, Mamont PS: Assay of α-difluoromethyornithine in body fluids and tissues by automatic amino-acid analyzer. J Chromatogr 223:409-416, 1981.
12. Ota DM, Grossie VB Jr, Ajani JA, Stephens LC, Nishioka K: Red blood cell polyamine levels and host toxicity during continuous alpha-difluoromethylornithine infusion. Int J Cancer 38:245-249, 1986.
13. Sjoholm A, Bucht E, Theodorsson E, Larsson R, Nygren P: Polyamines regulate human medullary thyroid carcinoma T-cell proliferation and secretion of calcitonin and calcitonin gene-related peptide. Mol Cell Endocrinol 103: 89-94, 1994.